Ablexis, LLC

In June 2018, Ablexis LLC, and Deerfield Management announced the acquisition of Ablexis by Deerfield. This acquisition creates a long-term partnership that will enable Ablexis to expand industry access to its AlivaMab® Mouse technology, the Company’s next-generation transgenic mouse platform for human antibody drug discovery.